Klaria Pharma Holding AB (publ.) Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Scott Boyer
Chief executive officer
SEK 1.6m
Total compensation
| CEO salary percentage | 95.4% |
| CEO tenure | 4.8yrs |
| CEO ownership | 0.6% |
| Management average tenure | no data |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -SEK 45m |
| Mar 31 2024 | n/a | n/a | -SEK 42m |
| Dec 31 2023 | SEK 2m | SEK 2m | -SEK 36m |
| Sep 30 2023 | n/a | n/a | -SEK 39m |
| Jun 30 2023 | n/a | n/a | -SEK 45m |
| Mar 31 2023 | n/a | n/a | -SEK 49m |
| Dec 31 2022 | SEK 2m | SEK 2m | -SEK 64m |
| Sep 30 2022 | n/a | n/a | -SEK 90m |
| Jun 30 2022 | n/a | n/a | -SEK 89m |
| Mar 31 2022 | n/a | n/a | -SEK 91m |
| Dec 31 2021 | SEK 2m | SEK 2m | -SEK 54m |
| Sep 30 2021 | n/a | n/a | -SEK 31m |
| Jun 30 2021 | n/a | n/a | -SEK 30m |
| Mar 31 2021 | n/a | n/a | -SEK 24m |
| Dec 31 2020 | SEK 2m | SEK 2m | -SEK 51m |
| Sep 30 2020 | n/a | n/a | -SEK 40m |
| Jun 30 2020 | n/a | n/a | -SEK 34m |
| Mar 31 2020 | n/a | n/a | -SEK 31m |
| Dec 31 2019 | SEK 2m | SEK 2m | -SEK 22m |
| Sep 30 2019 | n/a | n/a | -SEK 25m |
| Jun 30 2019 | n/a | n/a | -SEK 24m |
| Mar 31 2019 | n/a | n/a | -SEK 26m |
| Dec 31 2018 | SEK 2m | SEK 2m | -SEK 27m |
| Sep 30 2018 | n/a | n/a | -SEK 33m |
| Jun 30 2018 | n/a | n/a | -SEK 28m |
| Mar 31 2018 | n/a | n/a | -SEK 22m |
| Dec 31 2017 | SEK 2m | SEK 2m | -SEK 22m |
Compensation vs Market: Scott's total compensation ($USD155.87K) is below average for companies of similar size in the German market ($USD510.54K).
Compensation vs Earnings: Scott's compensation has been consistent with company performance over the past year.
CEO
Scott Boyer (62 yo)
4.8yrs
Tenure
SEK 1,589,000
Compensation
Mr. Scott Boyer is Director of Klaria Pharma Holding AB (publ.) from 2015 and also serves as Chief Executive Officer since October 25, 2023 and also served as Chief Scientific Officer from November 28, 201...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 9.7yrs | SEK 1.59m | 0.56% SEK 50.3k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.7yrs | SEK 200.00 | no data | |
| Chairman | 4.7yrs | SEK 1.24m | 2.93% SEK 261.0k | |
| Member of the Scientific Advisory Board | no data | no data | no data |
4.7yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 6FN's board of directors are considered experienced (4.7 years average tenure).